Citation: | LIN Li, YE Peipei, LI Shuangyue, YU Zhuruohan. A case report of spinal infection caused by Stenotrophomonas maltophilia following allogeneic hematopoietic stem cell transplantation[J]. Chinese Journal of General Practice, 2024, 22(8): 1446-1448. doi: 10.16766/j.cnki.issn.1674-4152.003656 |
[1] |
BITTENCOURT M C, CIUREA S O. Recent advances in allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia[J]. Biol Blood Marrow Transplant, 2020, 26(9): e215-e221. doi: 10.1016/j.bbmt.2020.06.007
|
[2] |
胡付品, 郭燕, 朱德妹, 等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2020, 20(1): 1-10.
HU F P, GUO Y, ZHU D M, et al. 2018 CHINET bacterial resistance monitoring in China[J]. Chinese Journal of Infection and Chemotherapy, 2020, 20(1): 1-10.
|
[3] |
BROOKE J S. Advances in the microbiology of Stenotrophomonas maltophilia[J]. Clin Microbiol Rev, 2021, 34(3): e0003019. DOI: 10.1128/CMR.00030-19.
|
[4] |
ISOM C M, FORT B, ANDERSON G G. Evaluating metabolic pathways and biofilm formation in Stenotrophomonas maltophilia[J]. J Bacteriol, 2022, 204(1): e398. DOI: 10.1128/jb.00398-21.
|
[5] |
SCHEICH S, KOENIG R, WILKE A C, et al. Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival[J]. PLoS One, 2018, 13(7): e0201169. DOI: 10.1371/journal.pone.0201169.
|
[6] |
SABURI M, OSHIMA K, TAKANO K, et al. Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group[J]. Ann Hematol, 2023, 102(9): 2507-2516. doi: 10.1007/s00277-023-05320-4
|
[7] |
ABAD C L, PHUOC V, KAPOOR P, et al. Bone and joint infections among hematopoietic stem cell transplant recipients[J]. J Bone Jt Infect, 2019, 4(5): 209-215. doi: 10.7150/jbji.38120
|
[8] |
TSANTES A G, PAPADOPOULOS D V, VRIONI G, et al. Spinal infections: an update[J]. Microorganisms, 2020, 8(4): 476. doi: 10.3390/microorganisms8040476
|
[9] |
ALJAWADI A, JAHANGIR N, JEELANI A, et al. Management of Pyogenic Spinal Infection, review of literature[J]. J Orthop, 2019, 16(6): 508-512. doi: 10.1016/j.jor.2019.08.014
|
[10] |
SATO K, YAMADA K, YOKOSUKA K, et al. Pyogenic spondylitis: clinical features, diagnosis and treatment[J]. Kurume Med J, 2018, 65(3): 83-89. doi: 10.2739/kurumemedj.MS653001
|
[11] |
邓亚开, 陈伟南. 胫腓骨开放性骨折后感染患者降钙素原与C反应蛋白水平变化及其诊断意义[J]. 中华全科医学, 2020, 18(10): 1663-1666. doi: 10.16766/j.cnki.issn.1674-4152.001587
DENG Y K, CHEN W N. The detection and diagnosis value of PCT and CRP in patients with open fracture of tibia and fibula[J]. Chinese Journal of General Practice, 2020, 18(10): 1663-1666. doi: 10.16766/j.cnki.issn.1674-4152.001587
|
[12] |
石仕元, 胡胜平, 费骏, 等. 宏基因组二代测序技术在脊柱非结核感染性疾病诊断中的应用价值[J]. 中华骨科杂志, 2022, 42(15): 961-967.
SHI S Y, HU S P, FEI J, et al. Application value of metagenomic next generation sequencing in the diagnosis of non-tuberculous spinal infection[J]. Chinese Journal of Orthopaedics, 2022, 42(15): 961-967.
|
[13] |
GIL-GIL T, MARTÍNEZ J L, BLANCO P. Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge[J]. Expert Rev Anti Infect Ther, 2020, 18(4): 335-347. doi: 10.1080/14787210.2020.1730178
|
[14] |
GALES A C, SEIFERT H, GUR D, et al. Antimicrobial susceptibility of Acinetobacter calcoaceticus: Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997-2016)[J]. Open Forum Infect Dis, 2019, 6(Suppl_1): S34-S46.
|
[15] |
GAJDÁCS M, URBÁN E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot[J]. Health Serv Res Manag Epidemiol, 2019, 6: 1-9.
|
[16] |
TAMMA P D, AITKEN S L, BONOMO R A, et al. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections[J]. Clin Infect Dis, 2023, 22: 1-53.
|
[17] |
GIAMPAOLINI N, BERDINI M, ROTINI M, et al. Non-specific spondylodiscitis: a new perspective for surgical treatment[J]. Eur Spine J, 2022, 31(2): 461-472. doi: 10.1007/s00586-021-07072-z
|